Oragenics, Inc.
OGEN
$0.86
$0.000.40%
AMEX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 107.00% | 31.68% | |||
| Gross Profit | -107.00% | -31.68% | |||
| SG&A Expenses | 73.42% | -24.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 82.23% | -15.40% | |||
| Operating Income | -82.23% | 15.40% | |||
| Income Before Tax | -34.97% | -2.48% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -34.97% | -2.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -34.97% | -2.48% | |||
| EBIT | -82.23% | 15.40% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 36.72% | 14.98% | |||
| Normalized Basic EPS | 36.72% | 14.98% | |||
| EPS Diluted | 36.72% | 14.98% | |||
| Normalized Diluted EPS | 36.72% | 14.98% | |||
| Average Basic Shares Outstanding | 113.30% | 20.54% | |||
| Average Diluted Shares Outstanding | 113.30% | 20.54% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||